July 26, 2022 02:08 PM EDT
Deals
China
Pharma

Mer­ck­'s ADC hunt con­tin­ues with sec­ond deal for Chi­na biotech Kelun

Kyle LaHucik

Senior Reporter

Two months af­ter ink­ing a rel­a­tive­ly qui­et $47 mil­lion up­front deal with Chi­na’s Kelun Biotech, Mer­ck is back with an­oth­er deal, this time eye­ing an …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

Trump names Johns Hop­kins re­searcher Mar­ty Makary to lead the FDA; al­so names CDC, Sur­geon Gen­er­al picks

FDA ap­proves Bridge­Bio's heart dis­ease drug, set­ting up com­pe­ti­tion with Pfiz­er, Al­ny­lam

Drug or bi­o­log­ic? An Eli Lil­ly law­suit could im­pact weight loss drug com­pounders

FDA vac­cine chief Pe­ter Marks pledges to stay as long as he's wel­come

Pa­tient dies in Neu­ro­gene's Rett syn­drome study

sponsored

Are pro­grams with com­pound­ed GLP-1s safe for your pop­u­la­tion?

A service from the Financial Times